BSN CAPITAL PARTNERS 13F: Exits JPMorgan Chase (JPM) Stake

BSN Capital Partners closed out its position in JPMorgan Chase & Co. JPM, selling all 100,000 shares during the period according to an October 23, 2026 SEC filing. The stock closed at $331.58 on the filing date.

JPM JPMorgan Chase & Co.

$332.04 ▲ +3.98% year to date

1M 3M YTD

Daily close · Oct 23, 2026

What Changed in Bsn Capital Partners's JPMorgan Chase & Co. Position

The firm completely exited its investment by liquidating all 100,000 shares it previously held, bringing its stake down to zero. That wiped out the entire prior position without leaving any residual shares.

Other Institutional Activity in JPMorgan Chase & Co.

Other major holders adjusted their positions around the same time. Sepio Capital reduced its holdings by 3,344 shares, ending with 2,293 shares worth about $758,905. Axxcess Wealth Management cut its stake by 57,078 shares, finishing with 79,512 shares valued at approximately $26.3 million. Smith Chas P & Associates Pa Cpas trimmed its position by 16,212 shares to hold 272,271 shares worth about $92.5 million. Meanwhile, Pictet North America Advisors grew its holdings by 2,648 shares, ending with 67,484 shares worth about $22.3 million. Accurate Wealth Management added 3,475 shares for a total of 42,201 shares valued at about $14.0 million.

JPMorgan Chase & Co. Stock Down 1.1%

JPMorgan recently traded around $331.57 as of October 24, 2026, sitting below its 50-day moving average and above its 200-day moving average. The shares have traded between a 52-week low of $279.10 and a 52-week high of $366.50.

Recent Earnings

JPMorgan posted trailing-twelve-month revenue of $190.7 billion and earnings of $23.84 per share. The bank recorded a net profit margin of 34.6% and a return on equity of 18.0%, with its next earnings report scheduled for January 14, 2027.

Dividend

The company pays an annual dividend rate of $6.60 per share, which translates to a dividend yield of 1.96% based on a payout ratio of 25.7%.

Insider Buying and Selling at JPMorgan Chase & Co.

Company insiders executed several transactions prior to the filing. General Counsel Stacey R. Friedman sold 5,468 shares on May 20, 2026, at an average price of $300.27 for a total of $1,641,856. Friedman later sold 5,467 shares on June 22, 2026, at $330.73 per share totaling $1,808,121. Officer Robin Leopold sold 2,500 shares on August 11, 2026, at $361.41 per share worth $903,518, and another 2,500 shares on September 10, 2026, at $352.81 per share for a total of $882,026.

Analysts Set New Price Targets

Analyst firms adjusted their views ahead of the filing period. Truist Securities maintained a hold rating on October 14, 2026, with a price target of $361.00. Barclays maintained an overweight rating on the same day, lifting its target to $425.00. RBC Capital reiterated an outperform rating on October 14 with a $370.00 price target. Morgan Stanley maintained an equal-weight rating on October 14 with a target of $377.00. Citigroup maintained a neutral rating on October 15, adjusting its target to $350.00. Overall, the stock carries a consensus buy recommendation from 23 analyst opinions with a mean target price of $372.26.

About JPMorgan Chase & Co.

JPMorgan Chase operates as a global financial institution providing banking, investment, and wealth management services across consumer and commercial markets. As one of the largest financial firms in the world, its portfolio moves are closely watched by institutional investors tracking the broader banking sector.

Bottom Line

Investors tracking BSN Capital Partners will look to subsequent quarterly updates to see how the firm repositions its capital across the financial sector. The bank's next earnings report arrives in January 2027.